Overview Rating

Speculative

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Technicals Analysis

0100

Financials Analysis

0100

MiMedx Group (NASDAQ:MDXG) Stock Quotes, Forecast and News Summary

Q: What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Open	$7.46
Close	$7.38
Volume / Avg.	746.01K / 737.56K
Day Range	7.36 - 7.57
52 Wk Range	5.57 - 9.27
Market Cap	$1.09B
P/E Ratio	14.52
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	4.17%
Days to Cover	4.42

Recent News

Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes

Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery. Targeting a $3.9 billion market, MIMEDX products demonstrate a 97% wound closure rate for diabetic foot ulcers, cost-effectiveness, and significant growth potential.

Vandana Singh

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Mimedx Group Inc

Sector

Health Care

Industry

Biotechnology

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiMedx Group (MDXG) stock?

You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.

View our list of the best stock brokerages

Who are MiMedx Group (MDXG) competitors?

Other companies in MiMedx Group’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).

What is the target price for MiMedx Group (MDXG) stock?

There is no analysis for MiMedx Group.

What is the forecast for MiMedx Group (MDXG) stock?

MiMedx Group has a consensus price target of $13.83.

Current stock price for MiMedx Group (MDXG)?

The stock price for MiMedx Group (NASDAQ: MDXG) is $7.38 last updated Today at July 24, 2024 at 4:04 PM EDT.

Does MiMedx Group (MDXG) pay a dividend?

There are no upcoming dividends for MiMedx Group.

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

MiMedx Group’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is MiMedx Group (MDXG) going to split?

There is no upcoming split for MiMedx Group.

What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

MiMedx Group

MiMedx Group (MDXG) Forecast